Fetal Ebstein Anomaly and Tricuspid Valve Dysplasia Registry
NCT ID: NCT05225311
Last Updated: 2025-05-31
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
1500 participants
OBSERVATIONAL
2021-09-22
2055-09-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Given the rarity of the disease, a retrospective arm was added to the original prospective study in May 2024.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Genes Causing Ebstein's Anomaly
NCT00497705
Biomarker Study for Heart Failure in Children With Single Ventricle Physiology
NCT00571233
Influence of Genetic Polymorphisms on Ventricular Structure and Function in Patients With Single Ventricle Anatomy
NCT00165984
Etiologic Risk Factors of Cardiovascular Malformations
NCT00005153
Outcomes of Children With Congenital Single Ventricle Heart
NCT00266968
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Patients with Fetal Ebstein's Anomaly or Tricuspid Valve Dysplasia
Patients will be followed for life-long outcomes.
Observation
Patients will be followed by the registry for life-long outcomes.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Observation
Patients will be followed by the registry for life-long outcomes.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
1. Mothers may be enrolled at any gestational age, up to the day of pregnancy outcome (elective termination of pregnancy, demise, or live-birth)
2. Singletons, twins or higher order multiples may be included
2. Consent obtained at a participating site
Exclusion Criteria
2. Unable or unwilling to provide consent
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
The Hospital for Sick Children
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Lindsay Freud
Head of Fetal Cardiology
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
The Hospital for Sick Children
Toronto, Ontario, Canada
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
1000076991
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.